Brief: Onxeo Announces Positive Intermediate Results From First Part Of DRIIV-1B Study Evaluating Asidna™ In Combination With Chemotherapy

Valerio Therapeutics SA

18/09/2019 17:02

Sept 18 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO ANNOUNCES POSITIVE INTERMEDIATE RESULTS FROM THE
FIRST
PART OF THE DRIIV-1B STUDY EVALUATING ASIDNA™ IN COMBINATION
WITH CHEMOTHERAPY
    * STABILIZED DISEASE WITHOUT TUMOR PROGRESSION FOR TWO OF
THE
THREE TREATED PATIENTS WHO ARE STILL RECEIVING TREATMENT WITH
ASIDNA™ PLUS CARBOPLATIN
    * SATISFACTORY TOLERANCE ALLOWING THE CONTINUATION OF THE
STUDY
    * START OF THE SECOND PART OF THE STUDY TO EVALUATE ASIDNA™
IN
COMBINATION WITH CARBOPLATIN AND PACLITAXEL
    * PRELIMINARY RESULTS FROM THIS SECOND PART ARE EXPECTED AT
THE
END OF THE YEAR

Source text for Eikon:  ID:nBwc7TTtxa 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))